Chimeric Antigen Receptor T-Cell Therapy | Sattva S Neelapu, MD

Oncology Grand Rounds Series: Part 9 — Faculty Presentation 1: Chimeric antigen receptor (CAR) T-cell therapy for aggressive and indolent B-cell lymphomas — Dr Neelapu CNE information and select publications